J3358 HCPCS Level II code: Ustekinumab, for intravenous injection, 1 mg
J3358 is the HCPCS code for “Ustekinumab, for intravenous injection, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3358Ustekinumab, for intravenous injection, 1 mg
Short description: Ustekinumab, iv inject, 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J3358 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Cross-reference
- See Q9989
- Added
- Jan 1, 2018
Where J3358 sits
- 1J codesDrugs administered other than orally
- 2Active code J3358Ustekinumab, for intravenous injection, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3358 mean?
J3358 is the HCPCS code for “Ustekinumab, for intravenous injection, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3358?
CMS lists J3358’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3358
All J codesJ3315Injection, triptorelin pamoate, 3.75 mgJ3316Injection, triptorelin, extended-release, 3.75 mgJ3320Injection, spectinomycin dihydrochloride, up to 2 gmJ3350Injection, urea, up to 40 gmJ3355Injection, urofollitropin, 75 iuJ3357Ustekinumab, for subcutaneous injection, 1 mgJ3360Injection, diazepam, up to 5 mgJ3364Injection, urokinase, 5000 iu vialJ3365Injection, iv, urokinase, 250,000 i.u. vialJ3370Injection, vancomycin hcl, 500 mgJ3371Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mgJ3372Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg